D. E. Shaw & Co., Inc. Genocea Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.05 - $2.82 $22,031 - $30,306	-10,747 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $30,893 - $43,357	-10,653 Reduced 49.78%	10,747 $31,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $74,258 - $143,594	21,400 New	21,400 $84,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.